v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Total Shareholders' Equity Attributable to Bruker Corporation
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income, Net of tax
Noncontrolling Interests in Consolidated Subsidiaries
Redeemable Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2023 $ 1,394.6 $ 1,377.2 $ 1.7 $ (1,237.2) $ 282.9 $ 2,323.8 $ 6.0 $ 17.4 $ 18.7
Balance (in shares) at Dec. 31, 2023     145,164,826            
Balance Treasury Shares at Dec. 31, 2023       30,778,879          
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 3.4 3.4     3.4        
Stock options exercised (in shares)     146,765            
Restricted Stock units vested (in shares)     23,051            
Stock based compensation 4.6 4.6     4.6        
Employee stock purchase plan 0.2 0.2     0.2        
Cash dividends paid to common shareholders (7.3) (7.3)       (7.3)      
Loans to noncontrolling interest (0.9)             (0.9)  
Consolidated net income (loss) 52.3 50.9       50.9   1.4 (0.3)
Other comprehensive income (loss) (14.0) (13.7)         (13.7) (0.3) (0.5)
Balance at end of period at Mar. 31, 2024 1,432.9 1,415.3 $ 1.7 $ (1,237.2) 291.1 2,367.4 (7.7) 17.6 17.9
Balance ending (in shares) at Mar. 31, 2024     145,334,642            
Balance Treasury Shares at Mar. 31, 2024       30,778,879          
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 0.5 0.5     0.5        
Stock options exercised (in shares)     24,484            
Restricted Stock units vested (0.1) (0.1)     (0.1)        
Restricted Stock units vested (in shares)     1,404            
Stock based compensation 4.8 4.8     4.8        
Employee stock purchase plan 2.1 2.1     2.1        
Employee Stock Purchase Plan (in shares)     31,291            
Public Offering, net of issuance costs of $0.8 million 403.0 403.0 $ 0.1   402.9        
Public Offering, net of issuance costs of $0.8 million, shares     6,000,000            
Cash dividends paid to common shareholders (7.7) (7.7)       (7.7)      
Consolidated net income (loss) 7.9 7.6       7.6   0.3 (0.3)
Other comprehensive income (loss) (36.4) (36.3)         (36.3) (0.1) (0.1)
Balance at end of period at Jun. 30, 2024 1,807.0 1,789.2 $ 1.8 $ (1,237.2) 701.3 2,367.3 (44.0) 17.8 17.5
Balance ending (in shares) at Jun. 30, 2024     151,391,821            
Balance Treasury Shares at Jun. 30, 2024       30,778,879          
Balance at beginning of period at Dec. 31, 2024 1,797.1 1,781.2 $ 1.8 $ (1,237.2) 713.4 2,406.7 (103.5) 15.9 18.1
Balance (in shares) at Dec. 31, 2024     151,677,952            
Balance Treasury Shares at Dec. 31, 2024       30,778,879          
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 0.4 0.4     0.4        
Stock options exercised (in shares)     18,771            
Restricted Stock units vested (in shares)     24,999            
Stock based compensation 5.2 5.2     5.2        
Employee stock purchase plan 0.4 0.4     0.4        
Shares Repurchased (10.1) (10.1)   $ (10.0) (0.1)        
Shares Repurchased (in shares)     (200,731) 200,731          
Cash dividends paid to common shareholders (7.7) (7.7)       (7.7)      
Proceeds from the sale of (distributions to) noncontrolling interests, net (0.5)             (0.5)  
Consolidated net income (loss) 17.1 17.4       17.4   (0.3) (0.4)
Other comprehensive income (loss) 31.0 30.4         30.4 0.6 0.6
Balance at end of period at Mar. 31, 2025 1,832.9 1,817.2 $ 1.8 $ (1,247.2) 719.3 2,416.4 (73.1) 15.7 18.3
Balance ending (in shares) at Mar. 31, 2025     151,520,991            
Balance Treasury Shares at Mar. 31, 2025       30,979,610          
Increase (Decrease) in Stockholders' Equity                  
Stock options exercised 1.8 1.8     1.8        
Stock options exercised (in shares)     87,487            
Restricted Stock units vested (0.1) (0.1)     (0.1)        
Restricted Stock units vested (in shares)     7,334            
Stock based compensation 5.3 5.3     5.3        
Employee stock purchase plan 3.7 3.7     3.7        
Employee Stock Purchase Plan (in shares)     100,115            
Cash dividends paid to common shareholders (7.6) (7.6)       (7.6)      
Consolidated net income (loss) 6.0 7.6       7.6   (1.6) (1.7)
Certain other acquisitions                 28.3
Other comprehensive income (loss) (22.6) (23.9)         (23.9) 1.3 2.5
Balance at end of period at Jun. 30, 2025 $ 1,819.4 $ 1,804.0 $ 1.8 $ (1,247.2) $ 730.0 $ 2,416.4 $ (97.0) $ 15.4 $ 47.4
Balance ending (in shares) at Jun. 30, 2025     151,715,927            
Balance Treasury Shares at Jun. 30, 2025 30,979,610     30,979,610